News and Trends 11 Aug 2022
Acquisition of TeneoTwo and its clinical-stage T-cell engager completed
AstraZeneca has said today (August 11) that it has completed its purchase of TeneoTwo including its B-cell non-Hodgkin lymphoma drug candidate. The company made an upfront payment of $100 million…
